The Victoza shortage isn't over — here's where things stand in 2026

If you've been struggling to fill your Victoza prescription, you're not alone. The shortage of GLP-1 medications — including Victoza — has been one of the most persistent drug supply issues in recent years, and it's still affecting patients in 2026.

This post gives you a clear, up-to-date picture of what's happening with Victoza supply, why prices remain high, and what you can do right now.

Is Victoza still in shortage?

As of early 2026, Victoza remains in intermittent shortage across much of the United States. That means some pharmacies have it while others don't — and availability can change from week to week.

The FDA's drug shortage database has listed GLP-1 receptor agonists among medications with ongoing supply concerns. Novo Nordisk, the manufacturer of Victoza, has acknowledged the supply challenges and says they continue to invest in manufacturing expansion.

For more background, see our explainer on why Victoza is so hard to find.

Why is Victoza still hard to find?

The same factors that started the shortage continue to drive it:

• Record demand for GLP-1 medications. Prescriptions for the entire class — Victoza, Ozempic, Mounjaro, Trulicity — have surged as awareness of their benefits has grown.
• Manufacturing can't keep pace. Injectable medications require complex production processes. Expanding capacity takes significant time and investment.
• Off-label use for weight management. While Victoza is approved for type 2 diabetes, demand from off-label weight-loss prescribing adds pressure to an already strained supply.
• Distribution bottlenecks. Even when doses are produced, they don't always reach every pharmacy evenly.

What does Victoza cost in 2026?

Without insurance, Victoza typically costs between $1,000 and $1,300 per month. That price hasn't dropped significantly, making cost a major barrier for many patients.

There are ways to lower that cost:

• Novo Nordisk NovoCare savings card: Eligible commercially insured patients may pay as little as $25 per month.
• Patient assistance programs: Uninsured or underinsured patients may qualify for free medication through Novo Nordisk's PAP.
• Discount cards: Platforms like GoodRx, SingleCare, and RxSaver can reduce the cash price at some pharmacies.

For a full guide on saving money, read How to save money on Victoza in 2026.

Are there new options available?

The GLP-1 market continues to evolve. While Victoza remains a solid choice for many patients, newer medications offer some advantages:

• Mounjaro (Tirzepatide) — a dual GIP/GLP-1 agonist with strong efficacy data
• Rybelsus (oral Semaglutide) — a pill form of a GLP-1 for patients who prefer not to inject
• Ozempic (Semaglutide) — a once-weekly injectable with robust cardiovascular data

If you're considering a switch, our post on alternatives to Victoza walks through your options in detail.

How to find Victoza in stock right now

The most reliable way to check availability is to use a real-time pharmacy stock tracker:

1. Visit Medfinder
2. Search for Victoza
3. Enter your zip code
4. See which pharmacies near you have it in stock today

You can also try independent pharmacies, ask about restock schedules, and have your pharmacist place a direct order. For more strategies, see How to find Victoza in stock near you.

Final thoughts

The Victoza shortage has been frustrating for patients and providers alike. While supply is expected to gradually improve as manufacturing capacity expands, the reality in early 2026 is that finding Victoza still requires effort.

Stay informed, use tools like Medfinder, and keep an open line of communication with your doctor. You have more options than you might think — and you don't have to manage this alone.